Vaccines, Medicines and COVID-19 (Record no. 200457982)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04467nam a22005895i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20231109085847.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 211224s2022 sz | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783030891251 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-3-030-89125-1 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | TR-AnTOB |
| Language of cataloging | eng |
| Transcribing agency | TR-AnTOB |
| Description conventions | rda |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
| Classification number | WC 506 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MBN |
| Source | bicssc |
| Subject category code | MED076000 |
| Source | bisacsh |
| Subject category code | MBN |
| Source | thema |
| 096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) | |
| Classification number | WC506EBK |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | İngilizce |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Velásquez, Germán. |
| Relator term | author. |
| Relator code | aut |
| -- | http://id.loc.gov/vocabulary/relators/aut |
| 245 10 - TITLE STATEMENT | |
| Title | Vaccines, Medicines and COVID-19 |
| Medium | [electronic resource] : |
| Remainder of title | How Can WHO Be Given a Stronger Voice? / |
| Statement of responsibility, etc. | by Germán Velásquez. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. 2022. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Cham : |
| Name of producer, publisher, distributor, manufacturer | Springer International Publishing : |
| -- | Imprint: Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2022. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS | |
| File type | text file |
| Encoding format | |
| Source | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | SpringerBriefs in Public Health, |
| International Standard Serial Number | 2192-3701 |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter 1: COVID-19 Vaccines: Between Ethics, Health and Economics -- Chapter 2: Medicines and Intellectual Property: 10 Years of the WHO Global Strategy -- Chapter 3: Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 -- Chapter 4: Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock -- Chapter 5: Intellectual Property and Access to Medicines and Vaccines -- Chapter 6: The World Health Organization Reforms in the Time of COVID-19 -- Epilogue. |
| 506 0# - RESTRICTIONS ON ACCESS NOTE | |
| Terms governing access | Open Access |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Medicine, Preventive. |
| Topical term or geographic name entry element | Health promotion. |
| Topical term or geographic name entry element | Medical policy. |
| Topical term or geographic name entry element | Vaccines |
| General subdivision | Biotechnology. |
| Topical term or geographic name entry element | Biomaterials. |
| Topical term or geographic name entry element | Public health. |
| Topical term or geographic name entry element | Health Promotion and Disease Prevention. |
| Topical term or geographic name entry element | Health Policy. |
| Topical term or geographic name entry element | Biomaterials-Vaccines. |
| Topical term or geographic name entry element | Public Health. |
| 653 #0 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | COVID-19 |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | SpringerBriefs in Public Health, |
| International Standard Serial Number | 2192-3701 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/978-3-030-89125-1">https://doi.org/10.1007/978-3-030-89125-1</a> |
| Materials specified | Springer eBooks |
| Public note | Online access link to the resource |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | National Library of Medicine |
| Koha item type | E-Book |
No items available.
